Featured Post From StockTwits About GH

Liquid biopsies should be a MAJOR focus for anyone in genomics space imo. $GH is leading the way right now but keep an eye on $EXAS. Also I think what $PSNL is doing with pharma and their neoantigens is important.

Pan-cancer screening (ie screening for all cancers) will happen eventually, but when???

The world needs to invest heavily (our own investment $$ helps) in this as odds of survival are dramatically higher w/ early detection.

Others to watch:
$ILMN (via Grail acquisition)
$NTRA